Cypsedo (cipepofol)

New molecular entity

Region: 🇺🇸 US
Active substance: cipepofol
Company: Haisco
Status: Approved
FDA approval: Fri 29 May 2026
Designations: New molecular entity
Application: NDA220482
Official record: www.accessdata.fda.gov

Regulatory milestones

Fri 29 May 2026🇺🇸 FDA approval

FDA approves Cypsedo (cipepofol), a new medicine

Haisco; NDA220482; New molecular entity; emulsion · source

Follow Cypsedo

Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.

Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.